Transplantation and cellular therapy
Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Utility for Subacute Cognitive Monitoring after Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-Cell Therapy.
Christina Kazzi, Sarah P Griffith, Katherine Y Ko, Daniel J Pearce, Miriam Wronski, Nabil Seery, Robb Wesselingh, Tracie H Tan, Ty Simpson, Cassandra Abbott, Jian Li, Elizabeth Cole, Michael Westworth, Shafqat Inam, Tiffany Rushen
Published: 202510.1016/j.jtct.2025.11.031
Abstract
Cognitive dysfunction is a common manifestation of immune effector cell-associated neurotoxicity syndrome (ICANS) following chimeric antigen receptor (CAR) T-cell therapy. With CAR-T therapy indications rapidly expanding beyond traditional indication…
Preview only. Read the full abstract at the source